Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SDC3 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
mRNA | NFATC2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | TAS2R41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | CYR61 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ATXN2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | ABCD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | TSNAX-DISC1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | SMAGP | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | DNAJA4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | GPR75-ASB3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |